Retraction: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells

Changhwan Yoon et al. Clin Cancer Res. 2024.

. 2024 Oct 15;30(20):4802.

doi: 10.1158/1078-0432.CCR-24-2133.

No abstract available

Retraction of

RETRACTED: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.
Yoon C, Cho SJ, Aksoy BA, Park DJ, Schultz N, Ryeom SW, Yoon SS. Yoon C, et al. Clin Cancer Res. 2016 Feb 15;22(4):971-83. doi: 10.1158/1078-0432.CCR-15-1356. Epub 2015 Oct 19. Clin Cancer Res. 2016. Retraction in: Clin Cancer Res. 2024 Oct 15;30(20):4802. doi: 10.1158/1078-0432.CCR-24-2133. PMID: 26482039 Free PMC article. Retracted.

1. Yoon C, Cho S-J, Aksoy BA, Park DJ, Schultz N, Ryeom SW, et al. Chemotherapy resistance in diffuse-type gastric adenocarcinoma is mediated by RhoA activation in cancer stem-like cells. Clin Cancer Res 2016;22: 971–83. - PMC - PubMed
1. Huang C, Yoon C, Zhou X-H, Zhou Y-C, Zhou W-W, Liu H, et al. Retracted article: ERK1/2-nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas. Cell Death Dis 2020;11:266. - PMC - PubMed
1. Lin J-X, Yoon C, Li P, Ryeom SW, Cho S-J, Zheng C-H, et al. CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer. Br J Cancer 2020;123:1131–44. - PMC - PubMed
1. Yoon C, Lu J, Yi BC, Chang KK, Simon MC, Ryeom S, et al. Retracted article: PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas. Oncogenesis 2021;10:12. - PMC - PubMed